(MCHI) iShares MSCI China - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B6719

MCHI: Chinese Stocks, Equity Securities, Investment Fund

The iShares MSCI China ETF (NASDAQ:MCHI) is designed to track the performance of the Chinese equity securities markets, focusing on the top 85% of market capitalization in the H-shares and B-shares markets. By investing at least 80% of its assets in the component securities of the underlying index, the fund provides a representation of the Chinese markets performance.

The underlying index is a free float-adjusted market capitalization-weighted index, meaning that the largest and most liquid Chinese companies have a greater influence on the funds performance. As a non-diversified fund, MCHI may be more susceptible to market fluctuations and volatility, as its performance is closely tied to the performance of its constituent securities.

From a technical analysis perspective, the current price of $54.92 is above the 20-day simple moving average (SMA) of $54.39, indicating a short-term bullish trend. The 50-day SMA of $52.61 and 200-day SMA of $49.43 also suggest a longer-term uptrend. With an average true range (ATR) of 0.77, representing a 1.40% daily price movement, the fund is experiencing moderate volatility. Given the current technical indicators and fundamental data, including a substantial AUM of $6.258 billion, a forecast for the next quarter could be a continued upward trend, potentially reaching $60.00, driven by the ongoing growth of the Chinese equity markets and the funds tracking of the top 85% of market capitalization.

However, its essential to consider that the Chinese equity markets can be subject to regulatory changes, economic fluctuations, and geopolitical tensions, which may impact the funds performance. Therefore, its crucial to continuously monitor the market conditions and adjust the investment strategy accordingly. With the current market conditions and the funds characteristics, investors may want to consider a long-term investment approach, riding out potential short-term market fluctuations.

Additional Sources for MCHI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

MCHI ETF Overview

Market Cap in USD 6,259m
Category China Region
TER 0.59%
IPO / Inception 2011-03-29

MCHI ETF Ratings

Growth Rating -6.45
Fundamental -
Dividend Rating 42.5
Rel. Strength 15.7
Analysts -
Fair Price Momentum 51.80 USD
Fair Price DCF -

MCHI Dividends

Dividend Yield 12m 1.73%
Yield on Cost 5y 1.54%
Annual Growth 5y 5.17%
Payout Consistency 89.9%
Payout Ratio %

MCHI Growth Ratios

Growth Correlation 3m 10.1%
Growth Correlation 12m 79.1%
Growth Correlation 5y -66.5%
CAGR 5y -1.04%
CAGR/Max DD 5y -0.02
Sharpe Ratio 12m -0.21
Alpha 19.81
Beta 0.642
Volatility 23.95%
Current Volume 1898k
Average Volume 20d 1804.7k
What is the price of MCHI shares?
As of June 15, 2025, the stock is trading at USD 54.77 with a total of 1,897,971 shares traded.
Over the past week, the price has changed by -0.27%, over one month by +0.13%, over three months by -1.79% and over the past year by +28.67%.
Is iShares MSCI China a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares MSCI China is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -6.45 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MCHI is around 51.80 USD . This means that MCHI is currently overvalued and has a potential downside of -5.42%.
Is MCHI a buy, sell or hold?
iShares MSCI China has no consensus analysts rating.
What are the forecasts for MCHI share price target?
According to our own proprietary Forecast Model, MCHI iShares MSCI China will be worth about 57.9 in June 2026. The stock is currently trading at 54.77. This means that the stock has a potential upside of +5.7%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 57.9 5.7%